As of 2026-05-15, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is -2.81 USD. This ALDX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.66 USD, the upside of Aldeyra Therapeutics Inc is -269.40%.
Based on its market price of 1.66 USD and our intrinsic valuation, Aldeyra Therapeutics Inc (ALDX) is overvalued by 269.40%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.81 - -2.81 | -2.81 | -269.40% |
| P/E | (9.98) - (11.35) | (10.97) | -760.7% |
| DDM - Stable | (4.34) - (13.54) | (8.94) | -638.5% |
| DDM - Multi | (3.69) - (9.29) | (5.32) | -420.3% |
| Market Cap (mil) | 99.90 |
| Beta | 2.33 |
| Outstanding shares (mil) | 60.18 |
| Enterprise Value (mil) | 45.11 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.41% |
| Cost of Debt | 5.00% |
| WACC | 9.55% |